Animal Welfare in Studies on Murine Tuberculosis: Assessing Progress over a 12-Year Period and the Need for Further Improvement

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Franco, Nuno Henrique ^a   Correia Neves, Margarida ^b,c   Olsson, I Anna S ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TESTING REFINEMENT; ANIMAL WELFARE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DISTRESS SYNDROME; ENVIRONMENTAL EXPOSURE; EUTHANASIA; FEMALE; GENDER; GOVERNMENT REGULATION; INNATE IMMUNITY; MALE; MEDICAL LITERATURE; MEDICAL RESEARCH; MORBIDITY; MOUSE; MOUSE STRAIN; NONHUMAN; TREND STUDY; TUBERCULOSIS;

ANIMAL EXPERIMENTATION; ANIMAL WELFARE; ANIMALS; CHI-SQUARE DISTRIBUTION; DISEASE MODELS, ANIMAL; MICE; TUBERCULOSIS, PULMONARY;

ANIMALIA; MURINAE;

EID: 84868143706     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047723     Document Type: Article

References (61)

1. Russell WMS, Burch RL (1959) The principles of humane experimental technique [by] W.M.S. Russell and R.L. Burch; Burch RLja, editor. London: Methuen.
2. van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, et al. (2010) Can Animal Models of Disease Reliably Inform Human Studies? PLoS Med 7: e1000245.
3. Sena ES, van der Worp HB, Bath PMW, Howells DW, Macleod MR, (2010) Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy. PLoS Biol 8: e1000344.
4. Anonymous (2010) Animal instinct. Nature 468: 731-732.
5. Lawn SD, Zumla AI, (2011) Tuberculosis. The Lancet 378: 57-72.
6. Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, et al. (2010) The HIV-associated tuberculosis epidemic-when will we act? The Lancet 375: 1906-1919.
7. World Health Organization (2011) Global Tuberculosis Control: WHO report 2011. Geneva, Switzerland.
8. Kaufmann SHE, Hussey G, Lambert P-H, (2010) New vaccines for tuberculosis. The Lancet 375: 2110-2119.
9. Palomino JC, Ramos DF, da Silva PA, (2009) New Anti-Tuberculosis Drugs: Strategies, Sources and New Molecules. Current Medicinal Chemistry 16: 1898-1904.
10. Koul A, Arnoult E, Lounis N, Guillemont J, Andries K, (2011) The challenge of new drug discovery for tuberculosis. Nature 469: 483-490.
11. Flynn JL, (2006) Lessons from experimental Mycobacterium tuberculosis infections. Microbes and Infection 8: 1179-1188.
12. Apt A, Kramnik I, (2009) Man and mouse TB: Contradictions and solutions. Tuberculosis (Amsterdam) 89: 195-198.
13. Rylance J, Pai M, Lienhardt C, Garner P, (2010) Priorities for tuberculosis research: a systematic review. The Lancet Infectious Diseases 10: 886-892.
14. North RJ, Jung YJ, (2004) Immunity to tuberculosis. Annu Rev Immunol 22: 599-623.
15. Medina E, North RJ, (1998) Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology 93: 270-274.
16. Chackerian AA, Behar SM, (2003) Susceptibility to Mycobacterium tuberculosis: lessons from inbred strains of mice. Tuberculosis (Edinburgh, Scotland) 83: 279-285.
17. Cooper AM, (2009) Cell-Mediated Immune Responses in Tuberculosis. Annual Review of Immunology 27: 393-422.
18. Actor JK, Olsen M, Jagannath C, Hunter RL, (1999) Relationship of survival, organism containment, and granuloma formation in acute murine tuberculosis. Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research 19: 1183-1193.
19. Dunn PL, North RJ, (1996) Persistent infection with virulent but not avirulent Mycobacterium tuberculosis in the lungs of mice causes progressive pathology. J Med Microbiol 45: 103-109.
20. Rhoades ER, Frank AA, Orme IM, (1997) Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber Lung Dis 78: 57-66.
21. Abebe F, Mustafa T, Nerland AH, Bjune GA, (2006) Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease. Clinical and Experimental Immunology 143: 180-192.
22. Flynn JL, Chan J, (2001) Tuberculosis: latency and reactivation. Infect Immun 69: 4195-4201.
23. Mustafa T, Phyu S, Nilsen R, Jonsson R, Bjune G, (1999) A mouse model for slowly progressive primary tuberculosis. Scandinavian Journal of Immunology 50: 127-136.
24. Markova N, Kussovski V, Drandarska I, Nikolaeva S, Georgieva N, et al. (2003) Protective activity of Lentinan in experimental tuberculosis. International Immunopharmacology 3: 1557-1562.
25. O'Connor JC, Andre C, Wang Y, Lawson MA, Szegedi SS, et al. (2009) Interferon-{gamma} and Tumor Necrosis Factor-{alpha} Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-Guerin. J Neurosci 29: 4200-4209.
26. Urdahl KB, Liggitt D, Bevan MJ, (2003) CD8(+) T cells accumulate in the lungs of Mycobacterium tuberculosis-infected Kb-/-Db-/- mice, but provide minimal protection. Journal of Immunology 170: 1987-1994.
27. Gupta UD, Katoch VM, (2005) Animal models of tuberculosis. Tuberculosis 85: 277-293.
28. Morton DB (1999) Humane endpoints in animal experimentation for biomedical research. In: Hendriksen CFM, Morton DB, editors. Humane endpoints in animals experiments for biomedical research. London: Royal Society of Medicine Press. 5-12.
29. OECD (2000) Guidance document on the recognition, assessment and use of clinical signs as humane endpoints for experiemental animal used in safety evaluation. Paris: Organisation for Economic Co-operation and Development.
30. Smith JA, van den Broek FAR, Martorell JC, Hackbarth H, Ruksenas O, et al. (2007) Principles and practice in ethical review of animal experiments across Europe: summary of the report of a FELASA working group on ethical evaluation of animal experiments. Laboratory Animals 41: 143-160.
31. EC (2010) Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. In: Commission E, editor. Brussels: Official Journal of the European Union. 33-79.
32. Kondratieva E, Logunova N, Majorov K, Averbakh M, Apt A (2010) Host Genetics in Granuloma Formation: Human-Like Lung Pathology in Mice with Reciprocal Genetic Susceptibility to M. tuberculosis and M. avium. PLoS ONE 5.
33. Yuan R, Tsaih SW, Petkova SB, de Evsikova CM, Xing SQ, et al. (2009) Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels. Aging Cell 8: 277-287.
34. Franco NH, Correia-Neves M, Olsson IAS, (2012) How "Humane" Is Your Endpoint?-Refining the Science-Driven Approach for Termination of Animal Studies of Chronic Infection. PLoS Pathog 8: e1002399.
35. Orme IM, Collins FM (1994) Mouse model of tuberculosis. In: Bloom BR, editor. Tuberculosis: Pathogenesis, Protection, and Control. Washington: American Society for Microbiology. 113-134.
36. Wald C, Wu C, (2010) Of Mice and Women: The Bias in Animal Models. Science 327: 1571-1572.
37. Beery AK, Zucker I, (2011) Sex bias in neuroscience and biomedical research. Neuroscience & Biobehavioral Reviews 35: 565-572.
38. Kilkenny C, Parsons N, Kadyszewski E, Festing MFW, Cuthill IC, et al. (2009) Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using Animals. PLoS ONE 4: e7824.
39. Smith JA, Birke L, Sadler D, (1997) Reporting animal use in scientific papers. Laboratory Animals 31: 312-317.
40. Sánchez F, Radaeva TV, Nikonenko BV, Persson A-S, Sengul S, et al. (2003) Multigenic Control of Disease Severity after Virulent Mycobacterium tuberculosis Infection in Mice. Infect Immun 71: 126-131.
41. Lavebratt C, Apt AS, Nikonenko BV, Schalling M, Schurr E, (1999) Severity of Tuberculosis in Mice is Linked to Distal Chromosome 3 and Proximal Chromosome 9. J Infect Dis 180: 150-155.
42. Mitsos L-M, Cardon LR, Ryan L, LaCourse R, North RJ, et al. (2003) Susceptibility to tuberculosis: A locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs. Proceedings of the National Academy of Sciences 100: 6610-6615.
43. Neyrolles O, Quintana-Murci L, (2009) Sexual Inequality in Tuberculosis. PLoS Med 6: e1000199.
44. McClelland E, Smith J, (2011) Gender Specific Differences in the Immune Response to Infection. Archivum Immunologiae et Therapiae Experimentalis 59: 203-213.
45. Olsson IAS, Hansen AK, Sandøe P, (2007) Ethics and Refinement in Animal Research. Science 317: 1680.
46. MacCallum CJ, (2010) Reporting Animal Studies: Good Science and a Duty of Care. PLoS Biol 8: e1000413.
47. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG, (2010) Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. PLoS Biol 8: e1000412.
48. Hooijmans CR, Leenaars M, Ritskes-Hoitinga M, (2010) A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible. Alternatives to laboratory animals: ATLA 38: 167-182.
49. Hagelin J, Hau J, Carlsson H-E, (2003) The refining influence of ethics committees on animal experimentation in Sweden. Lab Anim 37: 10-18.
50. Smith JA, van den Broek FAR, Martorell JC, Hackbarth H, Ruksenas O, et al. (2007) Principles and practice in ethical review of animal experiments across Europe: summary of the report of a FELASA working group on ethical evaluation of animal experiments. Lab Anim 41: 143-160.
51. Canadian Council on Animal Welfare (1991) CCAC policy statement on: categories of invasiveness in animal experiments. See http://ccac.ca/en_/standards/policies/policy-categories_of_invasiveness (accessed 2012 Sept 28).
52. Stevenson MM, Kondratieva TK, Apt AS, Tam MF, Skamene E, (1995) In-vitro and in-vivo T-cell responses in mice during bronchopulmonary infection with mucoid pseudomonas-aeruginosa. Clinical and Experimental Immunology 99: 98-105.
53. Dormans J, Burger M, Aguilar D, Hernandez-Pando R, Kremer K, et al. (2004) Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clinical & Experimental Immunology 137: 460-468.
54. Eruslanov EB, Majorov KB, Orlova MO, Mischenko VV, Kondratieva TK, et al. (2004) Lung cell responses to M. tuberculosis in genetically susceptible and resistant mice following intratracheal challenge. Clinical & Experimental Immunology 135: 19-28.
55. Gaines Das R, North D, (2007) Implications of experimental technique for analysis and interpretation of data from animal experiments: outliers and increased variability resulting from failure of intraperitoneal injection procedures. Lab Anim 41: 312-320.
56. Morton DB, Jennings M, Buckwell A, Ewbank R, Godfrey C, et al. (2001) Refining procedures for the administration of substances. Lab Anim 35: 1-41.
57. Veziris N, Ibrahim M, Lounis N, Chauffour A, Truffot-Pernot C, et al. (2009) A Once-Weekly R207910-containing Regimen Exceeds Activity of the Standard Daily Regimen in Murine Tuberculosis. Am J Respir Crit Care Med 179: 75-79.
58. de Meijer VE, Le HD, Meisel JA, Puder M, (2010) Repetitive orogastric gavage affects the phenotype of diet-induced obese mice. Physiology & Behavior 100: 387-393.
59. Quenelle DC, Winchester GA, Staas JK, Barrow ELW, Barrow WW, (2001) Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid. Antimicrobial Agents and Chemotherapy 45: 1637-1644.
60. Kamala T, (2007) Hock immunization: A humane alternative to mouse footpad injections. Journal of Immunological Methods 328: 204-214.
61. Hendriksen C, Hau J (2011) Immunization for Production of Antibodies. In: Hau J, Schapiro SJ, editors. Handbook of Laboratory Animal Science, Volume I, Third Edition: CRC Press. 467-484.